Skip to content Skip to footer

A Comprehensive Investigation into the Prevalence and Genomic Characterization of ESBL-Producing E. coli in East Africa

Escherichia coli (E. coli) is notorious for causing nosocomial infections and enhancing the rampant spread of antimicrobial resistance (AMR), a global health threat manifesting in hospitals. In particular, AMR often restrict the effectiveness of antibiotics, a cornerstone of modern medicine, and can potentially usher in a feared post-antibiotic era. Among the various bacterial species, E. coli is gaining attention due to its propensity for acquiring extensive drug resistance, mainly through the production of enzymes called extended-spectrum β-lactamases (ESBLs), which deactivate a wide range of β-lactam antibiotics.

In an effort to address this issue within the African continent, a hospital-based longitudinal study was initiated, concentrating on understanding the AMR in clinical settings in Uganda and Tanzania. This study leveraged whole-genome sequencing (WGS) technology to detect and examine the genetic elements of ESBL-producing E. coli isolates.

A total of 142 multi-drug resistant E. coli isolates from both countries were sequenced, revealing a worrisome prevalence and diversity of AMR elements. Genetic mutations conferring drug resistances were also identified in this study, emphasizing the significant contribution of these mutations to the challenge of AMR.

The research team identified high frequencies of AMR genes in the isolates, including very high instances of genes like blaCTX−M−15, blaCTX−M−27, blaTEM−1B, which all contribute to resistance to Beta-lactam-penicillin inhibitors. Moreover, some strains containing virulence factors derived from other disease-causing bacteria like Shigella dysenteriae and Yersinia pestis were also identified.

From the study’s findings, it is clear that public health sectors in Africa are grappling with a significant E. coli problem. The sheer range and prevalence of AMR elements within these bacterial populations underline the urgent need for bolstering infection prevention controls and incorporating advanced methods like WGS in routine AMR surveillance programs. This will not only enable the detection and cataloging of bacterial resistance but also assist in tracking the spread and evolution of multi-drug resistant E. coli.

Ironically, the role of human activity in accelerating the development and spread of bacterial resistance cannot be overlooked. Therefore, this research underscores the need for interventions aimed at optimal antibiotic use in public health settings, which addresses the rampant and inappropriate use of antibiotics.

The study results also reiterate use of advanced genomic-based technologies like WGS, particularly when complemented with conventional microbiological techniques and susceptibility testing. With enormous volumes of genomic data, these methodologies can significantly expand our understanding and management of drug-resistant bacteria, minimizing the threat of AMR in healthcare settings. Importantly, this research also hints towards a future where WGS could become a routine part of public health strategies to fight against AMR.

Source: https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-023-08579-0

Sign Up to Our Newsletter

Be the first to know the latest updates

[yikes-mailchimp form="1"]